Forensic · CERS
CERUS CORP
Top signals
Officer Departure Recent
C-suite officer departure (Item 5.02) in the last 6 months.
+4
Bear case preview · free
Cerus Corp's low risk score is driven primarily by recent C-suite officer departure disclosed in Item 5.02, which warrants attention given the company's position in the blood safety and cellular therapy markets where continuity matters. While a single departure doesn't necessarily signal underlying business deterioration, the timing and level of the departing officer should be assessed against any concurrent changes in guidance, product pipeline, or operational strategy. Monitor the next 30-90 days for any follow-up SEC filings (8-K, 10-Q) that might clarify the departure rationale and whether additional executive changes or business headwinds emerge.
↑ That's free. The $9 report goes deeper: every filing cited by accession number, 36-month chronology, what to watch next.
What we checked
✓ Red flags · 36mo
2 8-K events (bankruptcy, delisting, restatement, auditor, officer)
✓ Cyber · 12mo
0 Item 1.05 disclosures + buried-cyber scan
✓ Dilution · 24mo
0 S-3 + 424B5 filings
✓ Buried events
Item 8.01 sections classified for hidden material disclosures
$9
· one-time · emailed in under a minute
The full bear case on CERS
Plain-English brief. Every signal cited to the exact SEC filing. 36-month chronology. What changes next.
✓ No-signals refund: if the algorithm finds zero red flags on your ticker, reply "refund" and I send the $9 back same day. No questions.
Not ready to buy? Get a free preview by email instead
We'll email you the top 3 signals on CERS + a discount code for the full report. No subscription, no spam.
Score another ticker
Not investment advice. Every signal grounded in a specific SEC filing. Companies may respond via info@filingfirehose.com.